Comparative efficacy and safety of mycophenolate mofetil and azathioprine in combination with corticosteroids in the treatment of lymphocytic myocarditis by R. S. Rud, O. V. Blagova, E. A. Kogan, V. M. Novosadov, A. Yu. Zaitsev, V. P. Sedov, V. A. Zaydenov, A. G. Kupriyanova, V. V. Kadochnikova, A. E. Donnikov, A. V. Nedostup

Subjects: Get full text

COVID-19 Pneumonia in Patients with Chronic Myocarditis (Recurrent Infectious Immune): Specifics of the Diseases Course, the Role of Basic Therapy (Part 1) by O. V. Blagova, N. V. Varionchik, M. M. Beraia, V. A. Zaidenov, E. A. Kogan, N. D. Sarkisova, A. V. Nedostup

“…The article describes a 31-year-old patient with a 10-year history of chronic recurrent infectious-immune myocarditis, who was on long-term immunosuppressive therapy (methylprednisolone and azathioprine in the past, then hydroxychloroquine). In May 2020, a serologically confirmed COVID-19 diagnosis was made. …”
Get full text

Combination of chronic myocarditis and progressive coronary artery disease: differential diagnosis and stepwise treatment by Yu. A. Lutokhina, O. V. Blagova, V. P. Sedov, V. A. Zaidenov, A. V. Nedostup

“…IST was started with azathioprine 150 mg/day. We noted dyspnea relief and a stable increase in LVEF to 50-52%. …”
Get full text

Long-term Results of Drug and Interventional Treatment in Patients with Morphologically Verified Idiopathic Arrhythmias by O. V. Blagova, A. V. Nedostup, E. A. Kogan

“…All patients with myocarditis/vasculitis (n=15) received its basic therapy: acyclovir (n=10); immunoglobulin G 10-12.5 g (n=2); hydroxychloroquine 200 mg/day (n=15); glucocorticoids (n=14); azathioprine 150 mg/day (n=2). The late results were evaluated in all patients with myocarditis. …”
Get full text

Infectious-immune pericarditis: clinical assessment, diagnostics, and differentiated baseline therapy with hydroxychloroquine by O. V. Blagova, G. Yu. Sorokin, V. P. Sedov, E. A. Kogan, N. D. Sarkisova, A. V. Nedostup

“…Baseline therapy included NSAIDs (34,1%), colchicine (27,3%), hydroxychloroquine (43,2%), methylprednisolone (56,8%, 16 [16; 21] mg/day), azathioprine (20,5%). The treatment scheme was selected individually. …”
Get full text

CLINICAL AND MORPHOLOGICAL APPROACH TO DIAGNOSIS OF "IDIOPATHIC" ARRHYTHMIAS AND DILATED CARDIOMYOPATHY SYNDROME AS A BASIS FOR DIFFERENTIATED THERAPY. Part II (Treatment) by O. V. Blagova, A. V. Nedostup, E. A. Kogan, V. A. Sulimov, Yu. V. Osipova, V. P. Sedov, A. G. Kupriyanova, V. A. Zaydenov, A. E. Donnikov, V. V. Kadochnikova

“…The algorithm of noninvasive nosological diagnostics was developed; it allowed to verify diagnosis in 95% of IA patients and 89% DCM patients</p><p>The basic therapy (antiviral drugs, corticosteroids, hydroxychloroquine, azathioprine) was performed in some patients with myocarditis. …”
Get full text

Effectiveness of myocarditis therapy depending on the diagnosis approach (with or without myocardial biopsy) by O. V. Blagova, A. V. Nedostup, V. P. Sedov, A. Yu. Zaitsev, V. M. Novosadov, E. A. Kogan

“…The groups were completely comparable in age, baseline parameters (class III [2,25; 3] and III [2; 3] heart failure (HF); end-diastolic LV dimension, 6,7±0,7 and 6,4±0,7 cm; EF, 29,9±8,7 and 31,4±9,3%), the extent of cardiac therapy (excluding the administration rate of в-blockers — 94,4 and 78,7%, p&lt;0,05) and 1ST (methylprednisolone in 91,7 and 89,4% of patients at a mean dose of 24 [16; 32] and 20 [15; 32] mg/day, azathioprine in 50,0 and 46,8% of patients at a mean dose of 150 mg/day or mycophenolate mofetil 2,0 g/day in 30,6% in group 1, hydroxychloroquine 0,2 g/day in 27,8 and 23,4%). …”
Get full text

DCMP AS A CLINICAL SYNDROME: RESULTS OF NOSOLOGICAL DIAGNOSTICS WITH MYOCARDIAL BIOPSY AND DIFFERENTIATED TREATMENT IN VIRUS-POSITIVE AND VIRUS-NEGATIVE PATIENTS by O. V. Blagova, A. V. Nedostup, E. A. Kogan, V. P. Sedov, A. V. Donnikov, V. V. Kadochnikova, V. A. Zaydenov, A. G. Kupriyanova, V. A. Sulimov

“…If there was tolerance to cardiotropic therapy and high immune activity, immune suppression therapy (IST) was ordered: in 51% of virus-positive and 62,7% virus-negative patients: steroids 30 [22; 40] and 24 [16; 32] mg/day, azathioprin 1-2 mg/kg, hydroxychloroquine 200 mg/day. …”
Get full text